{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:20:59Z","timestamp":1789035659467,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":487,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12603-022-1825-5","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T12:02:53Z","timestamp":1658318573000},"page":"778-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of Antiresorptive Treatment in Osteoporotic Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials"],"prefix":"10.1016","volume":"26","author":[{"given":"Bernardo Abel","family":"Cedeno-Veloz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Erviti Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guti\u00e9rrez-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Leache Alegr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Rodr\u00edguez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"S\u00e1nchez Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ram\u00edrez V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mart\u00ednez-Velilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1007\/s12603-022-1825-5_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.berh.2017.10.001","article-title":"Fragility fractures & their impact on older people","volume":"31","author":"S\u00e0nchez-Riera","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1007\/s12603-022-1825-5_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2088","article-title":"Overdiagnosis of bone fragility in the quest to prevent hip fracture","volume":"350","author":"J\u00e4rvinen","year":"2015","journal-title":"BMJ."},{"key":"10.1007\/s12603-022-1825-5_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00265","article-title":"Rethinking the appraisal and approval of drugs for fracture prevention","volume":"8","author":"Erviti","year":"2017","journal-title":"Front Pharmacol."},{"issue":"2","key":"10.1007\/s12603-022-1825-5_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.11005\/jbm.2020.27.2.119","article-title":"The effect of denosumab on bone mass in super elderly patients","volume":"27","author":"Jeong","year":"2020","journal-title":"J Bone Metab."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cger.2016.08.003","article-title":"A review of osteoporosis in the older adult","volume":"33","author":"Alejandro","year":"2017","journal-title":"Clin Geriatr Med."},{"issue":"10","key":"10.1007\/s12603-022-1825-5_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/M14-0317","article-title":"Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review","volume":"161","author":"Crandall","year":"2014","journal-title":"Ann Intern Med."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib7","volume":"16","year":"2016","journal-title":"BMC Geriatr"},{"issue":"3","key":"10.1007\/s12603-022-1825-5_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.afos.2020.07.002","article-title":"Comparison of morbidity and mortality of hip and vertebral fragility fractures: which one has the highest burden?","volume":"6","author":"Rizkallah","year":"2020","journal-title":"Osteoporos Sarcopenia"},{"issue":"10122","key":"10.1007\/s12603-022-1825-5_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","article-title":"Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial","volume":"391","author":"Shepstone","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1007\/s12603-022-1825-5_bib10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/jamainternmed.2019.2779","article-title":"Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis","volume":"179","author":"Cummings","year":"2019","journal-title":"JAMA Intern Med."},{"key":"10.1007\/s12603-022-1825-5_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.archger.2017.05.017","article-title":"A systematic review of trends in the selective exclusion of older participant from randomised clinical trials","volume":"72","author":"Thake","year":"2017","journal-title":"Arch Gerontol Geriatr."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib12","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/EJE-17-0585","article-title":"Bone turnover markers: are they clinically useful?","volume":"178","author":"Eastell","year":"2018","journal-title":"Eur J Endocrinol."},{"key":"10.1007\/s12603-022-1825-5_bib13","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"10.1007\/s12603-022-1825-5_bib14","unstructured":"European Medicines Agency. Clinical safety data management: definitions and standards for expedited reporting (CPMP\/ICH\/377\/95). 1995. https:\/\/www.ema.europa.eu\/docs\/enGB\/documentlibrary\/scientificguideline\/2009\/09\/WC500002749.pdf; Accessed March 13, 2021."},{"key":"10.1007\/s12603-022-1825-5_bib15","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ WV (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2. https:\/\/training.cochrane.org\/handbook\/current. Published 2021. Accessed March 13, 2021."},{"issue":"9041","key":"10.1007\/s12603-022-1825-5_bib16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"9","key":"10.1007\/s12603-022-1825-5_bib17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","article-title":"Early changes in biochemical markers of bone turnover predict the long- term response to alendronate therapy in representative elderly women: a randomized clinical trial","volume":"13","author":"Greenspan","year":"1998","journal-title":"J Bone Miner Res."},{"issue":"10","key":"10.1007\/s12603-022-1825-5_bib18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.7326\/0003-4819-136-10-200205210-00009","article-title":"Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities: a randomized, double-blind, placebo-controlled trial","volume":"136","author":"Greenspan","year":"2002","journal-title":"Ann Intern Med."},{"issue":"6","key":"10.1007\/s12603-022-1825-5_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00198-008-0767-z","article-title":"Effect of alendronate in elderly patients after low trauma hip fracture repair","volume":"20","author":"Cecilia","year":"2009","journal-title":"Osteoporos Int."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1359\/jbmr.061008","article-title":"Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study","volume":"22","author":"McCloskey","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"8","key":"10.1007\/s12603-022-1825-5_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1007\/s12603-022-1825-5_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02242451","article-title":"The effect of a modified etidronate cyclical regimen on postmenopausal osteoporosis: a four-year study","volume":"16","author":"Lyritis","year":"1997","journal-title":"Clin Rheumatol."},{"issue":"5","key":"10.1007\/s12603-022-1825-5_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med."},{"issue":"18","key":"10.1007\/s12603-022-1825-5_bib24","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med."},{"issue":"18","key":"10.1007\/s12603-022-1825-5_bib25","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00198-016-3736-y","article-title":"Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)","volume":"28","author":"Nakamura","year":"2017","journal-title":"Osteoporos Int."},{"issue":"3","key":"10.1007\/s12603-022-1825-5_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00198-020-05637-0","article-title":"Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture","volume":"32","author":"Zhu","year":"2021","journal-title":"Osteoporos Int."},{"issue":"5","key":"10.1007\/s12603-022-1825-5_bib28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1359\/jbmr.040116","article-title":"Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study","volume":"19","author":"McCloskey","year":"2004","journal-title":"J Bone Miner Res."},{"issue":"6","key":"10.1007\/s12603-022-1825-5_bib29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1359\/jbmr.2002.17.6.1057","article-title":"Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension","volume":"17","author":"Brumsen","year":"2002","journal-title":"J Bone Miner Res."},{"issue":"14","key":"10.1007\/s12603-022-1825-5_bib30","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"J Am Med Assoc."},{"issue":"18","key":"10.1007\/s12603-022-1825-5_bib31","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis","volume":"367","author":"Boonen","year":"2012","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1007\/s12603-022-1825-5_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/os.12460","article-title":"Study on zoledronic acid reducing acute bone loss and fracture rates in elderly postoperative patients with intertrochanteric fractures","volume":"11","author":"Liu","year":"2019","journal-title":"Orthop Surg."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-799X-2-9","article-title":"Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis","volume":"2","author":"Qin","year":"2007","journal-title":"J Orthop Surg Res."},{"issue":"5","key":"10.1007\/s12603-022-1825-5_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF02896007","article-title":"Efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis","volume":"25","author":"Li","year":"2005","journal-title":"J Huazhong Univ Sci Technolog Med Sci."},{"issue":"7","key":"10.1007\/s12603-022-1825-5_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archinte.163.7.789","article-title":"Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial","volume":"163","author":"Ascott-Evans","year":"2003","journal-title":"Arch Intern Med."},{"issue":"6","key":"10.1007\/s12603-022-1825-5_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00774-003-0438-2","article-title":"Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis","volume":"21","author":"Chailurkit","year":"2003","journal-title":"J Bone Miner Metab."},{"issue":"2","key":"10.1007\/s12603-022-1825-5_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(99)80134-X","article-title":"Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling","volume":"99","author":"Chesnut","year":"1995","journal-title":"Am J Med."},{"issue":"2","key":"10.1007\/s12603-022-1825-5_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bone.2004.10.014","article-title":"The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study","volume":"36","author":"Leung","year":"2005","journal-title":"Bone."},{"issue":"22","key":"10.1007\/s12603-022-1825-5_bib39","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1007\/s12603-022-1825-5_bib40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"61","author":"McClung","year":"2006","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1007\/s12603-022-1825-5_bib41","first-page":"1116","article-title":"Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women","volume":"86","author":"Murphy","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"10.1007\/s12603-022-1825-5_bib42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos Int."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF01623461","article-title":"The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: results of three years of treatment","volume":"7","author":"Montessori","year":"1997","journal-title":"Osteoporos Int."},{"issue":"2","key":"10.1007\/s12603-022-1825-5_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"N Engl J Med."},{"key":"10.1007\/s12603-022-1825-5_bib45","unstructured":"European Medicines Agency. Scientific discussion: Aclasta EMEA-H-595-II-10-AR. 2007. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-discussion-variation\/aclasta-h-c-595-ii-10-epar-scientific-discussion-variation_en.pdf."},{"issue":"6","key":"10.1007\/s12603-022-1825-5_bib46","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/jc.2010-2784","article-title":"Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk","volume":"96","author":"Boonen","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"10.1007\/s12603-022-1825-5_bib47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.eurger.2010.08.002","article-title":"The evidence for antiresorptive osteoporosis treatment in the elderly and old","volume":"1","author":"Maraldo","year":"2010","journal-title":"Eur Geriatr Med."},{"issue":"3","key":"10.1007\/s12603-022-1825-5_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.regg.2018.11.007","article-title":"Efficacy, cost, and aspects to take into account in the treatment of osteoporosis in the elderly","volume":"54","author":"S\u00e1ez-L\u00f3pez","year":"2019","journal-title":"Rev Esp Geriatr Gerontol."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Arch Osteoporos."},{"issue":"2","key":"10.1007\/s12603-022-1825-5_bib50","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1532-5415.2009.02673.x","article-title":"Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older","volume":"58","author":"Boonen","year":"2010","journal-title":"J Am Geriatr Soc."},{"issue":"11","key":"10.1007\/s12603-022-1825-5_bib51","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1532-5415.2004.52506.x","article-title":"Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old","volume":"52","author":"Boonen","year":"2004","journal-title":"J Am Geriatr Soc."},{"issue":"6","key":"10.1007\/s12603-022-1825-5_bib52","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1359\/JBMR.050104","article-title":"Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures","volume":"20","author":"Hochberg","year":"2005","journal-title":"J Bone Miner Res."},{"issue":"6","key":"10.1007\/s12603-022-1825-5_bib53","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/joim.12678","article-title":"Hip fracture risk and safety with alendronate treatment in the oldest-old","volume":"282","author":"Axelsson","year":"2017","journal-title":"J Intern Med."},{"issue":"6","key":"10.1007\/s12603-022-1825-5_bib54","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/joim.12700","article-title":"The emperor redressed: treating osteoporosis to prevent hip fractures in the oldest old","volume":"282","author":"Abrahamsen","year":"2017","journal-title":"J Intern Med."},{"issue":"2","key":"10.1007\/s12603-022-1825-5_bib55","doi-asserted-by":"crossref","first-page":"e002084","DOI":"10.1136\/bmjopen-2012-002084","article-title":"Oral bisphosphonates may not decrease hip fracture risk in elderly Spanish women: a nested case-control study","volume":"3","author":"Erviti","year":"2013","journal-title":"BMJ Open."},{"issue":"12","key":"10.1007\/s12603-022-1825-5_bib56","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jbmr.2565","article-title":"Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996\u20132012: an ecological analysis","volume":"30","author":"Jha","year":"2015","journal-title":"J Bone Miner Res."},{"issue":"6","key":"10.1007\/s12603-022-1825-5_bib57","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/joim.12366","article-title":"Osteoporosis: the emperor has no clothes","volume":"277","author":"Jarvinen","year":"2015","journal-title":"J Intern Med."},{"issue":"8","key":"10.1007\/s12603-022-1825-5_bib58","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2213-8587(20)30159-5","article-title":"Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials","volume":"8","author":"Black","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1007\/s12603-022-1825-5_bib59","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2009-0852","article-title":"Effect of osteoporosis treatment on mortality: a meta-analysis","volume":"95","author":"Bolland","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"10.1007\/s12603-022-1825-5_bib60","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcms.2017.05.028","article-title":"What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a systematic review","volume":"45","author":"Aljohani","year":"2017","journal-title":"J Cranio-Maxillofacial Surg."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12603-015-0652-3","article-title":"Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: a systematic review","volume":"21","author":"Khow","year":"2017","journal-title":"J Nutr Heal Aging."},{"issue":"1","key":"10.1007\/s12603-022-1825-5_bib62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/jcm10010152","article-title":"Denosumab discontinuation and the rebound phenomenon: a narrative review","volume":"10","author":"Anastasilakis","year":"2021","journal-title":"J Clin Med."},{"issue":"3","key":"10.1007\/s12603-022-1825-5_bib63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5535\/arm.21110","article-title":"Clinical practice guideline for postoperative rehabilitation in older patients with hip fractures","volume":"45","author":"Min","year":"2021","journal-title":"Ann Rehabil Med."}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-022-1825-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12603-022-1825-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723008229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723008229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-022-1825-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:49:04Z","timestamp":1761137344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770723008229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1279770723008229"],"URL":"https:\/\/doi.org\/10.1007\/s12603-022-1825-5","relation":{},"ISSN":["1279-7707"],"issn-type":[{"value":"1279-7707","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Antiresorptive Treatment in Osteoporotic Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12603-022-1825-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SERDI Publisher.","name":"copyright","label":"Copyright"}]}}